Healthline: COVID-19 increases risk of mental health disorders
A new study of U.S. military veterans found that COVID-19 infection could increase the risk of developing mental health issues, even when compared to non-COVID patients or those who contracted the seasonal flu.
The study enrolled more than 150,000 veterans who had been infected with COVID-19 and compared them to a sample group of nearly 6 million veterans who had not contracted the virus. The participants were tracked over a one-year period.
The group who had recovered from COVID had 15 more cases of depression per 1,000 people, increased likelihood of sleeping problems, higher rates of alcohol and drug misuse and a nearly 50% increase in suicidal thoughts compared to the control group.
Maria Espinola, PsyD, assistant professor in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati College of Medicine, reviewed the study for Healthline and said the findings did not surprise her.
“Smaller studies have been showing a higher prevalence of certain mental health disorders among COVID patients,” Espinola told Healthline. "This study significantly increases our understanding of the problem.
"The findings add weight to the argument for integrated care, which refers to the integration of behavioral health services with general and/or specialty medical services,” Espinola continued.
Featured photo at top courtesy of the United States Marine Corps.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.